MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

Calling all vault hunters: If you need some fresh loot, we've got some Borderlands 3 Shift codes to help you get it. If you're looking for loot in the latest game, make sure to check our Borderlands 4 ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and educator with over ...